Bausch's Lumify Eye Drops Sales Jump To Double Competitors' Market Share

Lumify redness relief eye drops nearly doubled in sales between Bausch's second and third quarters and drove 7% organic growth of its global consumer business compared to the year-ago period. The brand has double the market share of its two closest competitors, and the firm plans clinical studies for product extensions to the brand in 2020.

third quarter business report target corporate financial result Q3 - Vector

Lumify OTC redness relief eye drops nearly doubled in sales between the second and third quarters to $21m and gained considerable share, accounting for double the market size of its closest competitors, Bausch Health Companies Inc. reported.

Lumify (brimonidine tartrate ophthalmic solution 0.025%) continues to “outpace expectations,” fueling 4.5% reported growth,7% organic, of Bausch’s global consumer business...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography